Running an unknown risk: A marathon death associated with the use of 1,3-dimethylamylamine (DMAA)

Drug Testing and Analysis

Volumn 7, Issue 5, 2015, Pages 433-438

  Archer, John R H ^a   Dargan, Paul I ^a,b   Lostia, Alfonso M ^c   van der Walt, Jon ^a   Henderson, Katherine ^a   Drake, Nicola ^a   Sharma, Sanjay ^d   Wood, David M ^a,b   Walker, Christopher J ^c   Kicman, Andrew T ^c  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

1,3 dimethylamylamine (DMAA); 4 methylhexane 2 amine; Fatality; Marathon; Recreational drug; Sports supplement

Indexed keywords

1,3 DIMETHYLAMYLAMINE; 4-METHYLHEXANE-2-AMINE; FATALITY; MARATHON; RECREATIONAL DRUGS; SPORT SUPPLEMENTS;

AMINES;

4 METHYL 2 HEXYLAMINE; ADRENALIN; BICARBONATE; DIAZEPAM; GLUCONATE CALCIUM; GLUCOSE; LACTIC ACID; MAGNESIUM SULFATE; NEUTRAL INSULIN; POTASSIUM; SODIUM; SODIUM CHLORIDE; 1,3-DIMETHYLAMYLAMINE; AMINE;

ACUTE HEART FAILURE; ADULT; AIRWAY; ALKALOSIS; ARTERIAL GAS; ARTICLE; AUTOMATED EXTERNAL DEFIBRILLATOR; AUTOPSY; BICARBONATE BLOOD LEVEL; CARBON DIOXIDE TENSION; CARDIOPULMONARY INSUFFICIENCY; CASE REPORT; CAUSE OF DEATH; COLLAPSE; DEATH; ECHOCARDIOGRAPHY; EGO DEVELOPMENT; ENDOTRACHEAL TUBE; EXERCISE; FATALITY; FEMALE; FORENSIC TOXICOLOGY; GLUCOSE BLOOD LEVEL; HEART ARREST; HEART RHYTHM; HUMAN; HUMAN TISSUE; HYPERKALEMIA; HYPOGLYCEMIA; LACTATE BLOOD LEVEL; LARYNGEAL MASK; LUNG EDEMA; MARATHON RUNNER; MUSCLE RIGIDITY; OXYGENATION; PH; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RECTUM TEMPERATURE; RESUSCITATION; RUNNING; SODIUM BLOOD LEVEL; BLOOD; DOPING;

ADULT; AMINES; DOPING IN SPORTS; FEMALE; HUMANS; RUNNING;

EID: 84929131009     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1764     Document Type: Article

References (45)

1. W. Fotheringham . Put Me Back on My Bike: In Search of Tom Simpson. Yellow Jersey Press. London, 2002.
2. World Anti-Doping Agency. The World Anti-Doping Code. The 2014 Prohibited List. International Standard. Available at http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-Prohibited-list/2014/WADA-prohibited-list-2014-EN.pdf [10 October 2014].
3. T.S. Miya, I. Edwards . A pharmacological study of certain alkoxyalkylamines. J. Pharm. Sci. 1953, 42, 107.
4. R. Charlier . Pharmacology of 2-amino-4-methylhexane. Arch. Int. Pharmacodyn. Ther. 1950, 83, 573.
5. Council on pharmacy and chemistry methylhexamine forthane (Lilly). JAMA 1950, 143, 1156.
6. National Institutes of Health. Office of Dietary Supplements. US Dietary Supplement Health and Education Act of 1994. Available at: http://ods.od.nih.gov/pdf/About/DSHEA_Wording.aspx.pdf [10 October 2014].
7. Z. Ping, Q. Jun, L. Qing . A study on the chemical constituents of geranium oil. J. Guizhou. Inst. Tech. 1996, 25, 82.
8. Y. Zhang, R.M. Woods, Z.S. Breitbach, D.W. Armstrong . 1, 3-Dimethylamylamine (DMAA) in supplements and geranium products: natural or synthetic? Drug Test. Anal. 2012, 4, 986.
9. H.L. Fleming, P.L. Ranaivo, P.S. Simone . Analysis and confirmation of 1, 3-DMAA and 1, 4-DMAA in geranium plants using high performance liquid chromatography with tandem mass spectrometry. Anal. Chem. Insights. 2012, 7, 59.
10. J.S. Li, M. Chen, Z.C. Li . Identification and quantification of dimethylamylamine in geranium by liquid chromatography tandem mass spectrometry. Anal. Chem. Insights 2012, 7, 47.
11. P.A. Cohen . In reply to Rodricks and Lumpkin. JAMA. Intern. Med. 2013, 173, 595.
12. A. Lisi, N. Hasick, R. Kazlauskas, C. Goebel . Studies of methylhexaneamine in supplements and geranium oil. Drug Test. Anal. 2011, 3, 873.
13. K.G. Austin, J. Travis, G. Pace, H.R. Lieberman . Analysis of 1, 3 dimethylamylamine concentrations in Geraniaceae, geranium oil and dietary supplements. Drug Test. Anal. 2014, 6, 797.
14. D. Lorenzo, E. Moro, A. Dos Santos, F. Uberti, P. Restani . Could 1, 3 dimethylamylamine (DMAA) in food supplements have a natural origin? Drug Test. Anal. 2013, 5, 116.
15. M.A. ElSohly, G. Waseem, T. Candice, K.M. ElSohly, T.P. Murphy, A. Avula, A.G. Chittiboyina, M. Wang, K.A. Ikhlas, M. Yang, G. Dean, W. Zhang, J. Sug . Methylhexanamine is not detectable in Pelargonium or Geranium species and their essential oils: A multi-centre investigation. Drug Test. Anal. 2014, DOI: 10.1002/dta.1726
16. DMAA. Drugs forum. Available at http://www.drugsforum.com/forum/showthread.php?t=140008 (last accessed 10 October 2014).
17. C. Kelleher, R. Christie, K. Lalor, J. Fox, C. O'Donnell . An Overview of New Psychoactive Substances and the Outlets Supplying Them. National Advisory Committee on Drugs Centre for Social and Educational Research, Dublin Institute of Technology, Dublin (Ireland), 2011.
18. P. Gee, S. Jackson, J. Easton . Another bitter pill: A case of toxicity from DMAA party pills. N.Z. Med. J. 2010, 123, 124.
19. World Anti-Doping Agency. The World Anti-Doping Code. 2010. The 2010 Prohibited List. International Standard. Available at http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-Prohibited-list/WADA_Prohibited_List_2010_EN.pdf [10 October 2014].
20. World Anti Doping Agency. Anti-Doping Testing Figures Report. Available at: http://www.wada-ama.org/Documents/Resources/Testing-Figures/WADA-2012-Anti-Doping-Testing-Figures-Report-EN.pdf [10 October 2014].
21. J.R.H. Archer, P.I. Dargan, H. Lee, S. Hudson, D.M. Wood . Trend analysis of anonymised pooled urine from portable street urinals in central London identifies variation in the use of novel psychoactive substances. Clin. Toxicol. 2014, 52, 160.
22. P.A. Cohen . DMAA as a dietary supplement ingredient. Arch. Intern. Med. 2012, 172, 1038.
23. M.J. Eliason, A. Eichner, A. Cancio, L. Bestervelt, B.D. Adams, P.A. Deuster . Case reports: Death of active duty soldiers following ingestion of dietary supplements containing 1, 2-dimethylamine (DMAA). Mil. Med. 2012, 177, 1455.
24. L. Perrenoud, M. Saugy, C. Saudan . Detection in urine of 4-methyl-2-hexaneamine, a doping agent. J. Chromatogr. B 2009, 877, 3767.
25. P.J. van der Merwe, S.E. Hendrikz . Identification of ephedrines as their carbon disulfide derivatives. J. Chromatogr. B 1995, 663, 160.
26. F.E. Critchfield, J.B. Johnson . Reaction of carbon disulfide with primary and secondary aliphatic amines as an analytic tool. Anal. Chem. 1956, 28, 430.
27. New Zealand Ministry of Health. Advice to the expert advisory committee on drugs on: Assessment of 1, 3 dimethylamylamine (DMAA). Available at: http://www.ndp.govt.nz/moh.nsf/Files/ndp-advice-docs/$file/advice-to-eacd-dmaa-aug-2009.pdf [10 October 2014].
28. L. Iverson, S. Gibbons, R. Treble, V. Setola, X. Huang, B. Roth . Neurochemical profiles of some novel psychoactive substances. Eur. J. Pharmacol. 2013, 700, 147.
29. N.J. Rahway (Ed). Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals, 11th edition.1989, 957, Merck Research Laboratories, Whitehouse Station, NJ, U. S.
30. D.F. Marsh, A. Howard, D.A. Herring . The comparative pharmacology of the isometric nitrogen methyl substituted heptylamines. J. Pharmacol. Exp. Ther. 1951, 103, 325.
31. E.E. Swanson, K.K. Chen . Comparison of pressor action of aliphatic amines. J. Pharmacol. Exp. Ther. 1946, 88, 10.
32. Q. Murphy, G.S. O'Brien, W.J. Meek . The effects of aliphatic sympathomimetic amines on cardiac automatic tissues in dogs under cyclopropane. Anesthesiology 1950, 11, 437.
33. B.K. Schilling, K.G. Hammond, R.J. Bloomer, C.S. Presley, C.R. Yates . Physiological and pharmacokinetic effects of oral 1, 3-dimethylamylamine administration in men. BMC Pharmacol. Toxicol. 2013, 14, 52.
34. R.J. Bloomer, I.C. Harvey, T.M. Farney, Z.W. Bell, R.E. Canale . Effects of 1, 3-dimethylamylamine and caffeine alone or in combination on heart rate and blood pressure in healthy men and women. Phys. Sportsmed. 2011, 39, 111.
35. C.G. Mcarthy, T.M. Farney, R.E. Canale, R.J. Allman, R.J. Bloomer . A finished dietary supplement stimulates lipolysis and metabolic rate in young men and women. Nutr. Metab. Insights 2012, 5, 23.
36. C.G. Mcarthy, R.E. Canale, R.J. Allman, J.P. Reed, R.J. Bloomer . Biochemical and anthropometric effects of a weight loss dietary supplement in healthy men and women. Nutr. Metab. Insights 2012, 5, 13.
37. T.M. Farney, C.G. Mcarthy, R.E. Canale, R.J. Allman R.J. Bloomer . Hemodynamic and hematologic profile of healthy adults ingesting dietary supplements containing 1, 3-dimethylamylamine and caffeine. Nutr. Metab. Insights 2012, 5, 1.
38. J. Long . Head shop drugs across Europe: Data from the EMCDDA. National Drugs Task Force Legal Highs Conference, Ireland, 26 January 2010, Mullingar, Ireland.
39. P. Gee, C. Tallon, N. Long, G. Moore, R. Boet, S. Jackson . Use of recreational drug 1, 3-dimethylethylamine (DMAA) associated with cerebral hemorrhage. Ann. Emerg. Med. 2012, 60, 431.
40. L. Salinger, B. Daniels, B. Sangalli . Recreational use of body-building supplement resulting in severe cardiotoxicity. Clin. Toxicol. 2011, 49, 573.
41. S. Davies, T. Lee, J. Ramsey, P.I. Dargan, D.M. Wood . Risk of caffeine toxicity associated with the use of 'legal highs' (novel psychoactive substances). Eur. J. Clin. Pharmacol. 2012, 68, 435.
42. W.S. Waring, W.J. Laing, A.M. Good, A.M. Malkowska . Acute caffeine ingestion: Clinical features in patients attending the emergency department and Scottish poison centre enquiries between 2000 and 2008. Scott. Med. J. 2009, 54, 3.
43. Food and Administration (FDA U.S.). DMAA in Dietary Supplements. Available at: http://www.fda.gov/food/dietarysupplements/qadietarysupplements/ucm346576.htm [10 October 2014].
44. 1, 3 Dimethylamylamine. Mother Nature's finest Natural Simulant - Smooth, Focused, and in Control! Available at: http://www.1-3-dimethylamylamine.com/ [10 October 2014].
45. Human Performance Resource Centre (HPRC). Dietary Supplements. Available at: http://hprc-online.org/dietary-supplements/files/dmaa-list-040114-pdf [10 October 2014].